Guha, Rajarshi
Vertex Pharmaceuticals, Inc.,
United States
2025 Rank: 56459
Overall Rank
Rank in SubField 1
Publications
Citations
Main Field:
Chemistry
SubField 1:
Medicinal & Biomolecular Chemistry
SubField 2:
Oncology & Carcinogenesis
Rank in SubField 1: 177 out of 112089 Researchers
Data For The Year: 2025
| Metrics | Self-Citations Excluded | All |
|---|---|---|
| Rank Based on Composite Score | 56459 | 59995 |
| Total Cites | 7974 | 9351 |
| H-index | 46 | 49 |
| Hm-index | 18 | 19 |
| Number of Single Authored Papers | 9 | 9 |
| Total Cites to Single Authored Papers | 523 | 533 |
| Number of Single+First Authored Papers | 37 | 37 |
| Total Cites to Single+First Authored Papers | 1957 | 2072 |
| Number of Single+First+Last Authored Papers | 51 | 51 |
| Total Cites to Single+First+Last Authored Papers | 2526 | 2693 |
| Composite Score | 3 | 3 |
| Number of Distinct Citing Papers | 7165 | 8132 |
| Ratio of Total Citations to Distinct Citing Papers | 1.11 | 1.15 |
| Self-Citation Percentage |
14.73%
|
|
Guha, Rajarshi
Vertex Pharmaceuticals, Inc.,
United States
2024 Rank: 57268
Overall Rank
Rank in SubField 1
Publications
Citations
Main Field:
Chemistry
SubField 1:
Medicinal & Biomolecular Chemistry
SubField 2:
Oncology & Carcinogenesis
Rank in SubField 1: 171 out of 105998 Researchers
Data For The Year: 2024
| Metrics | Self-Citations Excluded | All |
|---|---|---|
| Rank Based on Composite Score | 57268 | 60574 |
| Total Cites | 7234 | 8516 |
| H-index | 44 | 48 |
| Hm-index | 18 | 19 |
| Number of Single Authored Papers | 9 | 9 |
| Total Cites to Single Authored Papers | 474 | 484 |
| Number of Single+First Authored Papers | 36 | 36 |
| Total Cites to Single+First Authored Papers | 1833 | 1946 |
| Number of Single+First+Last Authored Papers | 50 | 50 |
| Total Cites to Single+First+Last Authored Papers | 2351 | 2509 |
| Composite Score | 3 | 3 |
| Number of Distinct Citing Papers | 6466 | 7362 |
| Ratio of Total Citations to Distinct Citing Papers | 1.12 | 1.16 |
| Self-Citation Percentage |
15.05%
|
|
Guha, Rajarshi
Vertex Pharmaceuticals, Inc.,
United States
2023 Rank: 54663
Overall Rank
Rank in SubField 1
Publications
Citations
Main Field:
Chemistry
SubField 1:
Medicinal & Biomolecular Chemistry
SubField 2:
Oncology & Carcinogenesis
Rank in SubField 1: 162 out of 99369 Researchers
Data For The Year: 2023
| Metrics | Self-Citations Excluded | All |
|---|---|---|
| Rank Based on Composite Score | 54663 | 57868 |
| Total Cites | 6858 | 8034 |
| H-index | 43 | 46 |
| Hm-index | 18 | 19 |
| Number of Single Authored Papers | 9 | 9 |
| Total Cites to Single Authored Papers | 426 | 436 |
| Number of Single+First Authored Papers | 39 | 39 |
| Total Cites to Single+First Authored Papers | 1816 | 1942 |
| Number of Single+First+Last Authored Papers | 53 | 53 |
| Total Cites to Single+First+Last Authored Papers | 2271 | 2436 |
| Composite Score | 3 | 3 |
| Number of Distinct Citing Papers | 6109 | 6936 |
| Ratio of Total Citations to Distinct Citing Papers | 1.12 | 1.16 |
| Self-Citation Percentage |
14.64%
|
|
Guha, Rajarshi
Vertex Pharmaceuticals, Inc.,
United States
2022 Rank: 55378
Overall Rank
Rank in SubField 1
Publications
Citations
Main Field:
Chemistry
SubField 1:
Medicinal & Biomolecular Chemistry
SubField 2:
Oncology & Carcinogenesis
Rank in SubField 1: 159 out of 94672 Researchers
Data For The Year: 2022
| Metrics | Self-Citations Excluded | All |
|---|---|---|
| Rank Based on Composite Score | 55378 | 57924 |
| Total Cites | 5933 | 7005 |
| H-index | 41 | 45 |
| Hm-index | 18 | 19 |
| Number of Single Authored Papers | 9 | 9 |
| Total Cites to Single Authored Papers | 363 | 373 |
| Number of Single+First Authored Papers | 40 | 40 |
| Total Cites to Single+First Authored Papers | 1686 | 1814 |
| Number of Single+First+Last Authored Papers | 53 | 53 |
| Total Cites to Single+First+Last Authored Papers | 2064 | 2225 |
| Composite Score | 3 | 3 |
| Number of Distinct Citing Papers | 5257 | 6009 |
| Ratio of Total Citations to Distinct Citing Papers | 1.13 | 1.17 |
| Self-Citation Percentage |
15.30%
|
|
Guha, Rajarshi
Vertex Pharmaceuticals, Inc.,
United States
2021 Rank: 57830
Overall Rank
Rank in SubField 1
Publications
Citations
Main Field:
Chemistry
SubField 1:
Medicinal & Biomolecular Chemistry
SubField 2:
Oncology & Carcinogenesis
Rank in SubField 1: 176 out of 88725 Researchers
Data For The Year: 2021
| Metrics | Self-Citations Excluded | All |
|---|---|---|
| Rank Based on Composite Score | 57830 | 60865 |
| Total Cites | 5495 | 6513 |
| H-index | 39 | 44 |
| Hm-index | 17 | 18 |
| Number of Single Authored Papers | 9 | 9 |
| Total Cites to Single Authored Papers | 340 | 350 |
| Number of Single+First Authored Papers | 39 | 39 |
| Total Cites to Single+First Authored Papers | 1616 | 1744 |
| Number of Single+First+Last Authored Papers | 52 | 52 |
| Total Cites to Single+First+Last Authored Papers | 1966 | 2127 |
| Composite Score | 3 | 3 |
| Number of Distinct Citing Papers | 4847 | 5557 |
| Ratio of Total Citations to Distinct Citing Papers | 1.13 | 1.17 |
| Self-Citation Percentage |
15.63%
|
|
Guha, Rajarshi
National Center for Advancing Translational Sciences,
United States
2020 Rank: 64782
Overall Rank
Rank in SubField 1
Publications
Citations
Main Field:
Chemistry
SubField 1:
Medicinal & Biomolecular Chemistry
SubField 2:
Oncology & Carcinogenesis
Rank in SubField 1: 247 out of 80622 Researchers
Data For The Year: 2020
| Metrics | Self-Citations Excluded | All |
|---|---|---|
| Rank Based on Composite Score | 64782 | 63271 |
| Total Cites | 4462 | 5307 |
| H-index | 36 | 42 |
| Hm-index | 16 | 17 |
| Number of Single Authored Papers | 9 | 9 |
| Total Cites to Single Authored Papers | 281 | 291 |
| Number of Single+First Authored Papers | 38 | 38 |
| Total Cites to Single+First Authored Papers | 1468 | 1593 |
| Number of Single+First+Last Authored Papers | 50 | 50 |
| Total Cites to Single+First+Last Authored Papers | 1733 | 1880 |
| Composite Score | 3 | 3 |
| Number of Distinct Citing Papers | 3886 | 4464 |
| Ratio of Total Citations to Distinct Citing Papers | 1.15 | 1.19 |
| Self-Citation Percentage |
15.92%
|
|
Related Profiles
Featured Profiles
Partner with TOPSCINET
Reach science enthusiasts and researchers across the site. Write to business@topscinet.com and our marketing team will send a proposal built around your banner ad goals.